Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2017 Jun;48(6):1501-1506.
doi: 10.1161/STROKEAHA.116.014537. Epub 2017 Apr 28.

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis)

Colin P Derdeyn  1 , David Fiorella  2 , Michael J Lynn  2 , Tanya N Turan  2 , George A Cotsonis  2 , Bethany F Lane  2 , Jean Montgomery  2 , L Scott Janis  2 , Marc I Chimowitz  2 ; SAMMPRIS Investigators
Affiliations
Randomized Controlled Trial

Nonprocedural Symptomatic Infarction and In-Stent Restenosis After Intracranial Angioplasty and Stenting in the SAMMPRIS Trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis)

Colin P Derdeyn et al. Stroke. 2017 Jun.

Abstract

Background and purpose: The purpose of this study was to investigate the frequency of symptomatic in-stent restenosis (ISR) and its contribution to nonprocedural symptomatic infarction in the SAMMPRIS trial (Stenting and Aggressive Medical Management for the Prevention of Recurrent Stroke in Intracranial Stenosis).

Methods: Patients without a periprocedural primary end point were followed up to determine the occurrence of any of the following events: ischemic stroke, cerebral infarct with temporary signs, or transient ischemic attack in the territory of the stented artery. Vascular imaging performed after these events was reviewed for ISR. Annual rates for symptomatic ISR were calculated using Kaplan-Meier estimates.

Results: Of 183 patients in the stenting group without a periprocedural primary end point, 27 (14.8%) had a symptomatic infarction (stroke or cerebral infarct with temporary signs) and 16 (8.7%) had transient ischemic attack alone in the territory during a median follow-up of 35.0 months. Of the 27 patients with infarctions, 17 (9.3%) had an ischemic stroke and 10 (5.5%) had a cerebral infarct with temporary signs alone. Adequate vascular imaging to evaluate ISR was available in 24 patients with infarctions (showing ISR in 16 [66.7%]) and in 10 patients with transient ischemic attack alone (showing ISR in 8 [80%]). The 1-, 2-, and 3-year rates (with 95% confidence limits) for symptomatic ISR in the SAMMPRIS stent cohort were 9.6% (6.1%-14.9%), 11.3% (7.5%-17.0%), and 14.0% (9.6%-20.2%), respectively.

Conclusions: Symptomatic ISR occurred in at least 1 of 7 patients in SAMMPRIS by 3 years of follow-up and was likely responsible for the majority of nonprocedural cerebral infarctions.

Clinical trial registration: URL: https://clinicaltrials.gov. Unique identifier: NCT00576693.

Keywords: Kaplan–Meier estimate; cerebral infarction; clinical trial; follow-up studies; stroke.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan Meier ISR curves
See this image and copyright information in PMC

References

    1. Chimowitz MI, Lynn MJ, Derdeyn CP, Turan TN, Fiorella D, Lane BF, et al. Stenting versus aggressive medical therapy for intracranial arterial stenosis. N Engl J Med. 2011;365:993–1003. - PMC - PubMed
    1. Derdeyn CP, Chimowitz MI, Lynn MJ, Fiorella D, Turan TN, Janis LS, et al. Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (sammpris): The final results of a randomised trial. Lancet. 2014;383:333–341. - PMC - PubMed
    1. Levy EI, Turk AS, Albuquerque FC, Niemann DB, Aagaard-Kienitz B, Pride L, et al. Wingspan in-stent restenosis and thrombosis: Incidence, clinical presentation, and management. Neurosurgery. 2007;61:644–650. discussion 650–641. - PubMed
    1. Yu SC, Leung TW, Lee KT, Wong LK. Angioplasty and stenting of intracranial atherosclerosis with the wingspan system: 1-year clinical and radiological outcome in a single asian center. J Neurointerv Surg. 2014;6:96–102. - PMC - PubMed
    1. Shin YS, Kim BM, Suh SH, Jeon P, Kim DJ, Kim DI, et al. Wingspan stenting for intracranial atherosclerotic stenosis: Clinical outcomes and risk factors for in-stent restenosis. Neurosurgery. 2013;72:596–604. discussion 604. - PubMed

Publication types

MeSH terms

Associated data